News
Aptamer Sciences Inc. has filed an IND application with the Korean Ministry of Food and Drug Safety seeking clearance to conduct a phase I trial of AST-201 in patients with GPC3-positive advanced ...
AST announces the launch of IP3 2024 (Industry Patent Purchase Program) that connects patent sellers with High Tech companies across the globe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback